Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 3, 2000, Pages 353-357

  Ferner, R E ^a   Lucas, J D ^b   O'Doherty, M J ^c   Hughes, R A C ^a   Smith, M A ^b   Cronin, B F ^c   Bingham, J ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b St Thomas's Soft Tissue Tumour Unit   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Malignant peripheral nerve; Neurofibromatosis 1; Plexiform neurofibroma; Sheath tumour

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERIPHERAL NERVE TUMOR; SCINTISCANNING; CANCER GRADING; CLINICAL ARTICLE; CLINICAL FEATURE; FOLLOW UP; GLUCOSE METABOLISM; HISTOLOGY; PAIN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SCHOOL CHILD; SYMPTOM;

ADOLESCENT; ADULT; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEUROFIBROMA; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033621549     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.3.353     Document Type: Review

References (17)

1. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in South East Wales. Brain 1988;111:1355-81.
2. National Institutes of Health Consensus Development Conference Statement Neurofibromatosis. Arch Neurol 1988;45:575-8.
3. Recklinghausen FD von. Über die Multiplen Fibrome der Haut und Ihre Beziehung zu den Multiplen Neuromen. Berlin: A Hirschwald, 1882.
4. Riccardi VM. Neurofibromatosis: phenotype natural history and pathogenesis. Baltimore: Johns Hopkins University Press, 1992:63-85.
5. Tonsgard JH, Short MP, Kwak S, et al., Computed tomographic imaging in neurofibromatosis. Neurology 1998;50:1755-60
6. Ducatman BS, Scheithauer BW, Piepgras DG et al., Malignant peripheral nerve sheath tumours, a clinicopathologic study of 120 cases. Cancer 1986;57:2006-21.
7. Lawrence W, Donegan WL, Natarajan N, et al., Adult soft-tissue sarcomas: a pattern of care survey by the American College of Surgeons. Ann Surg 1987;205:349-59.
8. Hermann G, Abdelwahab IF, Miller TT, et al. Tumour and tumour-like conditions of soft tissue: magnetic resonance imaging features differentiating benign from malignant masses. Br J Radiol 1992:65:14-20.
9. Stauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-48.
10. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumours by PET. J Nucl Med 1988;29:181-6.
11. Adler LP, Blair HF, Makley JT, et al. Non-invasive grading of musculoskeletal tumours using PET. J Nucl Med 1991;32: 1508-12.
12. Grifteth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft tissue masses with fluorine-18 fiuoro-2-deoxy-D-glucose. Radiology 1992;182:185-94
13. Nieweg OE, Pruim J, va Ginkel RJ, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996;37:257-61.
14. Eary JF, Mankfoff DA. Tumour metabolic rates in sarcoma using FDG PET. Jf Nucl Med 1998;39:250-4.
15. Lucas JD, O'Docherty MJ, Wong JCH, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. Br J Bone Joint Surg 1998;80:441-7.
16. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults: study of pathological prognostic variables and definitions of a histopathological grading system. Int J Cancer 1984;33:37-42.
17. 18FDG upake in soft tissue masses. Eur J Nucl Med 1999; 26:22-30.